Antibody therapy:Cancer 合杂末9科学 Strategies to enhance immune function Teffs 40 - Ant-418E Anti-LAG-3 AnU-GITR Tregs Myeloid(MΦ/MDsc/DC) Combinations Anti-CDZ3 Tumor al antibody Targeted the Mol0nc0l.2015Dec9(10y2043-205 临床免疫学数研室 http://ipkc.gdmc.edu.cn/ktiyy/ Monoclonal antibodies approved for solid malignancies and their clinical indications Target Approved clinical indication(s) ith chen nt of patient PFS,OS ar R:1 CHN ECFR tatic CRC with an entech. HER2 oved p lete res HER2 HER. eparately or in